Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S O Ogren

Showing results (191-200 of 257) with videos related to

Pageof 26
Sort By:
Neuroscience|July 26, 2005
Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing miceP Tovote, M Meyer, A Ronnenberg, et al.
Annals of the New York Academy of Sciences|June 12, 1978
5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neuronsK Fuxe, S O Ogren, L F Agnati, et al.
Journal of Medicinal Chemistry|January 1, 1978
Antidepressant agents. 9. 3,3-Diphenylcyclobutylamines, a new class of central stimulantsB Carnmalm, S Rämsby, A L Renyi, et al.
Journal of Medicinal Chemistry|August 1, 1990
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative studyT Högberg, T de Paulis, L Johansson, et al.
Neuroscience|October 1, 2011
Galanin differentially regulates acetylcholine release in ventral and dorsal hippocampus: a microdialysis study in awake ratT Yoshitake, S Yoshitake, S Savage, et al.
Acta Pharmaceutica Suecica|January 1, 1975
Antidepressant agents. VI. 4,4-Diphenyl-1-methylcyclohexylaminesB Carnmalm, M L Persson, S B Ross, et al.
Acta Pharmaceutica Suecica|January 1, 1975
Antidepressant agents. V. 1,1-Dimethyl-omega,omega-diphenylalkylaminesB Carnmalm, M L Persson, S B Ross, et al.
Psychopharmacology|November 1, 1994
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatumS Ferré, R Schwarcz, X M Li, et al.
Neuroscience Letters|March 31, 1987
Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortexJ T Cummins, G von Euler, K Fuxe, et al.
Toxicology|March 19, 1993
Persistent effects of subchronic toluene exposure on spatial learning and memory, dopamine-mediated locomotor activity and dopamine D2 agonist binding in the ratG von Euler, S O Ogren, X M Li, et al.
Pageof 26

Showing results (191-200 of 257) with videos related to

Sort By:
Pageof 26
Neuroscience|July 26, 2005
Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing miceP Tovote, M Meyer, A Ronnenberg, et al.
Annals of the New York Academy of Sciences|June 12, 1978
5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neuronsK Fuxe, S O Ogren, L F Agnati, et al.
Journal of Medicinal Chemistry|January 1, 1978
Antidepressant agents. 9. 3,3-Diphenylcyclobutylamines, a new class of central stimulantsB Carnmalm, S Rämsby, A L Renyi, et al.
Journal of Medicinal Chemistry|August 1, 1990
Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative studyT Högberg, T de Paulis, L Johansson, et al.
Neuroscience|October 1, 2011
Galanin differentially regulates acetylcholine release in ventral and dorsal hippocampus: a microdialysis study in awake ratT Yoshitake, S Yoshitake, S Savage, et al.
Acta Pharmaceutica Suecica|January 1, 1975
Antidepressant agents. VI. 4,4-Diphenyl-1-methylcyclohexylaminesB Carnmalm, M L Persson, S B Ross, et al.
Acta Pharmaceutica Suecica|January 1, 1975
Antidepressant agents. V. 1,1-Dimethyl-omega,omega-diphenylalkylaminesB Carnmalm, M L Persson, S B Ross, et al.
Psychopharmacology|November 1, 1994
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatumS Ferré, R Schwarcz, X M Li, et al.
Neuroscience Letters|March 31, 1987
Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortexJ T Cummins, G von Euler, K Fuxe, et al.
Toxicology|March 19, 1993
Persistent effects of subchronic toluene exposure on spatial learning and memory, dopamine-mediated locomotor activity and dopamine D2 agonist binding in the ratG von Euler, S O Ogren, X M Li, et al.
Pageof 26